Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01866956 · ClinicalTrials.gov registry record

Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders

A clinical trial of Psychiatric Disorder, sponsored by Center for Psychological Consultation.

Completed
Registry status
223
Enrollment target
2
Study locations

NCT01866956: Completed study of Psychiatric Disorder, sponsored by Center for Psychological Consultation.

NCT01866956 is a study of Psychiatric Disorder that has completed, run by Center for Psychological Consultation. The registered enrollment target is 223 participants, above the 117-participant average among 9 other Psychiatric Disorder trials with a reported enrollment target (91% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01866956, a study of Psychiatric Disorder, has completed, sponsored by Center for Psychological Consultation.

COMPLETED
Registry status
223 participants
Enrollment target
2
Study locations

Study Summary

The KSADS-COMP will facilitate identification of comorbid psychiatric and substance use diagnoses frequently missed in clinical practice, and improve adolescent treatment outcomes. The self-administered version of the KSADS-COMP can also be used cost-effectively in schools and juvenile justice settings where there is a growing interest in early identification and referral of youth in need of mental health services. The KSADS-Bridge assessment tool with its RDoC neurocognitive tasks, when completed with the self- or clinician administered KSADS-COMP, will help to create cross-talk between the DSM and RDoC diagnostic perspectives, and begin to generate a database on the relationship between RDoC constructs and treatment outcomes across a range of diagnostic categories.

Primary Outcome

compare scores on disorder-specific symptom rating scales between those with and without a specific diagnoses

Conditions Studied

Study Locations (2)

Maryland

  • Hugo W. Moser Research Institute at Kennedy Krieger - Baltimore

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2016-09-01
Est. Completion 2018-04-30

What the finished NCT01866956 record still lists

NCT01866956 is an observational study that tracks outcomes without assigning an intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, above the 117-participant average among 9 other Psychiatric Disorder trials with a reported enrollment target (91% higher).

The record links to 1 condition, with Psychiatric Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT01866956 reports a single indexed study location in Maryland, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01866956 about?

NCT01866956 is a clinical study titled "Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders". The KSADS-COMP will facilitate identification of comorbid psychiatric and substance use diagnoses frequently missed in clinical practice, and improve adolescent treatment outcomes. The self-administered version of the KSADS-COMP can also be used cost-effectively in schools and juvenile justice setti...

What is the current status of trial NCT01866956?

This trial is currently completed. The enrollment target is 223 participants. The study started on 2016-09-01. Estimated completion is 2018-04-30.

What conditions does trial NCT01866956 study?

This clinical trial studies the following conditions: Psychiatric Disorder.

Who is sponsoring clinical trial NCT01866956?

This trial is sponsored by Center for Psychological Consultation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01866956 being conducted?

This trial has 2 study locations across Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychiatric Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01866956's enrollment target sits among peer trials

223 2nd of 9 the highest of 9 other Psychiatric Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychiatric Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06640803 · 223 participants · NA

    Sacramento Clinical High Risk for Psychosis Stepped-Care Program

  • NCT07175285 · 223 participants

    A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • NCT07205718 · 223 participants · Phase 1

    A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01866956, the US trial registry maintained by the National Library of Medicine. NCT01866956 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.